AD36E4ORF1: a therapeutic treatment for Alzheimer's disease
AssigneeTexas Tech University System
InventorsNikhil V. Dhurandhar, Vijay Hegde
Life of this patent
Estimating the term…
Abstract
Embodiments of the present disclosure pertain to methods of treating or preventing Alzheimer's disease or symptoms of Alzheimer's disease in a subject by administering to the subject an active agent that includes an adenovirus-36 E4orf1 protein, a nucleic acid encoding an adenovirus-36 E4orfl protein, or combinations thereof. Additional embodiments of the present disclosure pertain to the active agents of the present disclosure for use in the treatment or prevention of Alzheimer's disease or symptoms of Alzheimer's disease.
Claims16
A method of treating or preventing Alzheimer's disease or symptoms of Alzheimer's disease in a subject, said method comprising:
- administering to the subject an active agent selected from the group consisting of an adenovirus-36 E4orf1 protein, a nucleic acid encoding an adenovirus-36 E4orf1 protein, or combinations thereof,
- wherein the subject has Alzheimer's disease or exhibits symptoms of Alzheimer's disease, and
- wherein the method treats Alzheimer's disease or symptoms of Alzheimer's disease by improving or maintaining the subject's cognition.
Dependencies are inferred from the claim text.